Roche gets FDA priority review for atezolizumabRoche is expanding its indications in cancer immunotherapy. Following FDA approvals of its PD-L1 checkpoint inhibitor atezolizumab in NSCLC and bladder cancer patients refractive to platinum-based chemotherapy, … more ➔
UK researchers find metastasis switch in breast cancer cellsConstitutive activation of the mechano-sensor and transcription factor Yes-associated protein (YAP) is key to metastasis and epithelial-mesenchymal transition of triple-negative breast cancer, researchers … more ➔
NeRRe Therapeutics pushes leads by €26m Series B financingNeuronal hypersensitivity specialist NeRRe Therapeutics has closed an oversubscribed Series B financing round led by Fountain Healthcare Partners. more ➔
Bayer antibiotics spin-out Aicuris bags IMI grantThe Innovative Medicines Initiative is pushing clinical development of a novel compound against Gram-negative bugs that cause urinary tract and intra-abdominal infections. Backed by IMI, Aicuris is launching … more ➔
Tiziana joins rheumatoid arthritis raceThe London-based immunotherapy specialist Tiziana Life Sciences bagged the license for the human anti-interleukin 6 receptor antagonist NI-1201 from Swiss Novimmune. more ➔
Sanofi and Boehringer Ingelheim close ?business swapFrench Sanofi is set to become a global market leader in the non-prescription market by acquiring Boehringer Ingelheim’s consumer healthcare (CHC) business in exchange for Sanofi’s animal health … more ➔
Best of 2016: Our most wanted newsWhich European Biotechnology news stories topped the charts this year? The European Biotechnology team delved into archives and analysed the click statistics. And here they are: the most wanted news … more ➔
Blood test on the scent of prionsContaminated blood can transmit prion disease even if the donor does not yet show any symptoms. A new blood test could make the blood supply safer. Two reports show it can correctly diagnose Variant … more ➔
IMI launches €348m callElectronic submission systems of the Innovative Medicines Initiative (IMI) will open for biotech companies and research groups on 4 January 2017 to apply for collaborative projects with pharma partners … more ➔
Belgian spin-off Indigo challenges diabetes giants Indigo Diabetes NV has been spun-off from University of Ghent and international research institute imec with a series A financing of €7m. The company’s needle-free glucose sensor addresses … more ➔
